![Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine | Journal of Neuroscience Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine | Journal of Neuroscience](https://www.jneurosci.org/content/jneuro/41/5/891/F1.large.jpg)
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine | Journal of Neuroscience
![Exploring the Long-Term Effects of Psychedelics on the Brain — BrainPost | Easy-to-read summaries of the latest neuroscience publications Exploring the Long-Term Effects of Psychedelics on the Brain — BrainPost | Easy-to-read summaries of the latest neuroscience publications](https://images.squarespace-cdn.com/content/v1/5a151755bff2007c8dffebcb/1582028630177-XD65HWARUV11IYIJ4G80/psilocybin_quote_Feb18.png)
Exploring the Long-Term Effects of Psychedelics on the Brain — BrainPost | Easy-to-read summaries of the latest neuroscience publications
![Psychedelic microdosing benefits and challenges: an empirical codebook | Harm Reduction Journal | Full Text Psychedelic microdosing benefits and challenges: an empirical codebook | Harm Reduction Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12954-019-0308-4/MediaObjects/12954_2019_308_Fig1_HTML.png)
Psychedelic microdosing benefits and challenges: an empirical codebook | Harm Reduction Journal | Full Text
![Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels | Neuropsychopharmacology Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels | Neuropsychopharmacology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41386-019-0324-9/MediaObjects/41386_2019_324_Fig2_HTML.png)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels | Neuropsychopharmacology
![Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study - eClinicalMedicine Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/3af8db7b-be6d-44c1-8067-46ca22b13f67/gr1.jpg)
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study - eClinicalMedicine
![Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms | Pharmacological Reviews Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/73/1/202/F1.large.jpg)
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms | Pharmacological Reviews
![Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-59282-y/MediaObjects/41598_2020_59282_Fig3_HTML.png)
Emotions and brain function are altered up to one month after a single high dose of psilocybin | Scientific Reports
![Frontiers | The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies Frontiers | The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies](https://www.frontiersin.org/files/Articles/739053/fphar-12-739053-HTML-r2/image_m/fphar-12-739053-g002.jpg)